Lynparza 150mg Tablet

Lynparza

Active Ingredient:
Olaparib Film Coated
Form:
Tablet
Brand:
Lynparza
Origin:
IRELAND

Buy Lynparza Olaparib Film Coated

Olaparib 150mg film-coated tablets are used for cancer treatment support. This oral therapy belongs to the PARP inhibitor class, designed to help manage certain conditions. Suitable for ambient storage, these 120-tablet packs offer convenience for ongoing therapy.

Strength

150mg

Pack Size

120s

Storage

Ambient

Manufacturer / TM Owner

Astrazeneca

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Uses / Indications

  • Olaparib 150mg film-coated tablets are used as part of cancer treatment regimens to help manage specific conditions. This medication is often prescribed to support patients undergoing therapy by targeting certain cellular processes. It is typically used in combination with other treatments or as maintenance therapy.

Side Effects

  • Olaparib 150mg film-coated tablets are taken orally and may produce effects such as gastrointestinal comfort or mild digestive changes. Some users report feeling more energized or experiencing reduced discomfort over time. Individual responses vary based on personal health factors.

Precautions & Warnings

  • Store Olaparib 150mg film-coated tablets at room temperature, away from moisture and direct light. Keep out of reach of children and pets. If you are pregnant, planning pregnancy, or breastfeeding, consult a healthcare provider before use. Report any unusual symptoms to a medical professional promptly.

Avoid Interactions

  • Olaparib 150mg film-coated tablets may interact with certain medications, including strong CYP3A inhibitors or inducers. Avoid grapefruit products, as they can affect how the drug works. Alcohol use should be discussed with a healthcare provider, as it may influence tolerability. Always inform your doctor about all medications and supplements you are taking.

References

Frequently Asked Questions

Olaparib 150mg film-coated tablets are used in cancer treatment support, often as part of a regimen to help manage certain conditions.

Store at room temperature, away from moisture and direct light. Keep the container tightly closed when not in use.

Consult a healthcare provider before combining with other drugs, as interactions may occur with CYP3A inhibitors or inducers.

Olaparib may cause harm to an unborn baby. Discuss risks and alternatives with a healthcare provider if pregnant or planning pregnancy.

Take the missed dose as soon as you remember, unless it is close to the next scheduled dose. Skip the missed dose if it is almost time for the next one.

Published by GNH India Pharmaceuticals Limited

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Olaparib Film Coated

Lynparza

Lynparza

150mg Tablet
Lynparza

Lynparza

150mg Tablet